<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>maintenance Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/maintenance/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Thu, 23 Nov 2023 20:38:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>maintenance Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Maintenance TMS</title>
		<link>https://www.gatewaypsychiatric.com/maintenance-tms/</link>
					<comments>https://www.gatewaypsychiatric.com/maintenance-tms/#respond</comments>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 02 Dec 2017 15:01:55 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[chronic depression]]></category>
		<category><![CDATA[maintenance]]></category>
		<category><![CDATA[tms]]></category>
		<category><![CDATA[treatment of depression]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=14882</guid>

					<description><![CDATA[<p>A patient with treatment resistant depression and an excellent initial response to TMS asked me about the value of maintenance TMS. The question is a reasonable one given what we know generally about the treatment of chronic and/or treatment resistant depression. Almost all of the effective treatments (psychotherapy, medications, ECT, etcetera) have acute and maintenance treatment components. And for all ... </p>
<div><a href="https://www.gatewaypsychiatric.com/maintenance-tms/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/maintenance-tms/">Maintenance TMS</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.gatewaypsychiatric.com/maintenance-tms/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14882</post-id>	</item>
		<item>
		<title>Long Acting Injectable Aripiprazole for Bipolar</title>
		<link>https://www.gatewaypsychiatric.com/long-acting-injectable-aripiprazole-bipolar/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Wed, 08 Feb 2017 01:04:40 +0000</pubDate>
				<category><![CDATA[Bipolar Treatment]]></category>
		<category><![CDATA[aripiprazole]]></category>
		<category><![CDATA[bipolar]]></category>
		<category><![CDATA[bipolar treatment]]></category>
		<category><![CDATA[long acting injectable]]></category>
		<category><![CDATA[maintenance]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[risperidone]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12301</guid>

					<description><![CDATA[<p>Long acting injectable aripiprazole for bipolar one patients has been shown to significantly reduce the risk of a recurrence of a mood episode in a 52 week placebo controlled clinical trial. Poor adherence to treatment is a significant problem in patients with bipolar disorder, putting patients at increased risk of recurrence of mood episodes, hospitalization, and suicide. One other study ... </p>
<div><a href="https://www.gatewaypsychiatric.com/long-acting-injectable-aripiprazole-bipolar/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/long-acting-injectable-aripiprazole-bipolar/">Long Acting Injectable Aripiprazole for Bipolar</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12301</post-id>	</item>
		<item>
		<title>TMS Guidelines</title>
		<link>https://www.gatewaypsychiatric.com/tms-guidelines/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 26 Jun 2016 17:33:37 +0000</pubDate>
				<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[effectiveness]]></category>
		<category><![CDATA[expert consensus]]></category>
		<category><![CDATA[guidelines]]></category>
		<category><![CDATA[maintenance]]></category>
		<category><![CDATA[reviews]]></category>
		<category><![CDATA[tms]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=11101</guid>

					<description><![CDATA[<p>In the April edition of Brain Stimulation, the Clinical TMS Society published expert consensus guidelines on the use of TMS. This definitive review of the literature identifies both what is known as well as significant areas of uncertainty about the use of TMS in the treatment of depression. The process of developing the guideline is described in the introduction to the ... </p>
<div><a href="https://www.gatewaypsychiatric.com/tms-guidelines/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/tms-guidelines/">TMS Guidelines</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">11101</post-id>	</item>
	</channel>
</rss>
